Network origin in Richard A. Farley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard A. Farley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| STAAR SURGICAL COMPANY | Medical Specialties | Director/Board Member | |
| CASSAVA SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| COMPUGEN LTD. | Biotechnology | Corporate Officer/Principal | |
| GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chairman | |
Curium Finland Oy
 Curium Finland Oy Miscellaneous Commercial ServicesCommercial Services MAP Medical Technologies Oy engages in the development and manufacture of radiopharmaceuticals and radiochemical products. It provides positron-emission tomography diagnostic agents and single-photon emission computed tomography products. The company was founded by Mika Nyyssönen and Jarmo Haukka on March 13, 1991 and is headquartered in Tikkakoski, Finland. | Miscellaneous Commercial Services | Chairman | |
| Wallac Oy | Corporate Officer/Principal | ||
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Fibrogen Europe Oy
 Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Biotechnology | Director/Board Member Chief Executive Officer | |
Innomedica Oy
 Innomedica Oy Miscellaneous Commercial ServicesCommercial Services Innomedica is an international business consulting company serving the biotechnology and pharmaceutical industries. It provides a range of professional business development and project management services to its clients in both the public and private sectors. Innomedica's service portfolio includes Business Development, Licensing & Partnering, Japan Markets and Project Management. It is active on a global basis, though it specializes in the North European and Japanese markets. Its people are its main asset. Its success is based on leveraging the experience of professionals from different disciplines to deliver value to its clients. Its team portrays backgrounds from experienced business people to skilled lawyers and biomedical scientists. Innomedica was founded in 1997, and is a privately held company. Its client base covers both private and public sectors, both large and small. | Miscellaneous Commercial Services | Chief Executive Officer | |
Catalyst, Inc.
 Catalyst, Inc. Miscellaneous Commercial ServicesCommercial Services Catalyst, Inc. provides research and advisory services. The company was founded in 1962 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| The Palo Alto Medical Foundation | Hospital/Nursing Management | Corporate Officer/Principal | |
Phadia AB
 Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Medical Specialties | Chief Executive Officer | |
Suomen Itsenäisyyden Juhlarahasto
 Suomen Itsenäisyyden Juhlarahasto Investment ManagersFinance Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years. | Investment Managers | Director/Board Member | |
Pherin Pharmaceuticals, Inc.
 Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Biotechnology | Chairman Director/Board Member | |
| UC Davis School of Medicine | College/University | Doctorate Degree | |
| Universidad del Valle | College/University | Undergraduate Degree | |
| Ark Therapeutics Oy | Director/Board Member | ||
| Lilly Diabetes | President Corporate Officer/Principal | ||
| A.B. Freeman School of Business | College/University | Masters Business Admin | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PERRIGO COMPANY PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Daniels College of Business | College/University | Masters Business Admin | |
| Ronald & Ann Williams Charitable Foundation | Chairman Director/Board Member | ||
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Bio Orbit Oy | Chairman | ||
| Biketex Ltd. | Chief Executive Officer | ||
| Cylon Capital KK | Corporate Officer/Principal | ||
Idea Development ID Oy
 Idea Development ID Oy Advertising/Marketing ServicesCommercial Services Idea Development ID Oy is an advertising agency based in Helsinki, Finland. The Finnish company operates as an advertising agency. | Advertising/Marketing Services | Chairman | |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| Pharmacia Diagnostics Production Oy | Chief Executive Officer | ||
| APOLLOMICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 30 |
| Finland | 13 |
| Ireland | 3 |
| Israel | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 89 |
| Corporate Officer/Principal | 54 |
| Independent Dir/Board Member | 25 |
| Undergraduate Degree | 21 |
| Chairman | 18 |
Most connected contacts
| Insiders | |
|---|---|
| Kalevi Kurkijärvi | 21 |
| Benjamin Cravatt | 19 |
| Enrique Conterno | 18 |
| Jeffrey Henderson | 18 |
| May Kin Ho | 16 |
| Kin Hung Yu | 15 |
| Roberto Pedro Rosenkranz | 15 |
| Julian N. Stern | 14 |
| Jeffrey Edwards | 13 |
| Aoife Brennan | 10 |
| Gerald Lema | 9 |
| Kirk A. Christoffersen | 9 |
| Frank Valone | 9 |
| Thomas Byron Neff | 8 |
| Suzanne Blaug | 8 |
- Stock Market
- Insiders
- Richard A. Farley
- Company connections
